Asset Details
Do you wish to reserve the book?
Challenges and advances in clinical applications of mesenchymal stromal cells
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Challenges and advances in clinical applications of mesenchymal stromal cells
Do you wish to request the book?
Challenges and advances in clinical applications of mesenchymal stromal cells
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Challenges and advances in clinical applications of mesenchymal stromal cells
2021
Overview
Mesenchymal stromal cells (MSCs), also known as mesenchymal stem cells, have been intensely investigated for clinical applications within the last decades. However, the majority of registered clinical trials applying MSC therapy for diverse human diseases have fallen short of expectations, despite the encouraging pre-clinical outcomes in varied animal disease models. This can be attributable to inconsistent criteria for MSCs identity across studies and their inherited heterogeneity. Nowadays, with the emergence of advanced biological techniques and substantial improvements in bio-engineered materials, strategies have been developed to overcome clinical challenges in MSC application. Here in this review, we will discuss the major challenges of MSC therapies in clinical application, the factors impacting the diversity of MSCs, the potential approaches that modify MSC products with the highest therapeutic potential, and finally the usage of MSCs for COVID-19 pandemic disease.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Animals
/ Artificial intelligence (AI)
/ Cloning
/ COVID-19
/ Extracellular Vesicles - genetics
/ Extracellular Vesicles - immunology
/ Extracellular Vesicles - transplantation
/ Genes
/ Genetic Engineering - methods
/ Humans
/ Medicine
/ Mesenchymal Stem Cell Transplantation - methods
/ Mesenchymal Stem Cells - cytology
/ Mesenchymal Stem Cells - immunology
/ Mesenchymal Stem Cells - metabolism
/ Oncology
/ Review
